Coherus BioSciences Inc (NASDAQ:CHRS)

15.06
BATS BZX Real-Time Price
As of 9:56am ET
 -0.44 / -2.84%
Today’s Change
8.32
Today|||52-Week Range
20.66
+66.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$986.3M

Company Description

Coherus BioSciences, Inc. is a commercial-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar, and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Contact Information

Coherus BioSciences, Inc.
333 Twin Dolphin Drive
Redwood City California 94065
P:(650) 649-3530
Investor Relations:
(650) 395-0196

Employees

Shareholders

Mutual fund holders45.63%
Other institutional43.10%
Individual stakeholders32.41%

Top Executives

Denny M. LanfearChairman, President & Chief Executive Officer
Vincent R. AnicettiChief Operating Officer
Jean-Frédéric ViretChief Financial Officer
Peter K. WatlerChief Technical Officer
Vladimir VexlerChief Scientific Officer